This page is dedicated to the Nephrotic Syndrome/Glomerular Disease research study, one of 57 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
The Nephrotic Syndrome/Glomerular Disease research study, established at Boston Children’s in 2021 and led by Dr. Matthew Sampson, has enrolled 210 patients and their families. The study aims to identify genetic causes of nephrotic syndrome/glomerular disease and provide personalized medicine.